Our primary goal is to attract investments in clinical trials for the benefit of patients. This is why we work closely with national and international bodies and organize studies that provide modern, up-to-date and comprehensive data in order to ensure that invaluable global medical knowledge is used to address the health challenges facing our country.
The benefits are multiple, primarily for the patients who participate in clinical trials, but also for the national economy:
• For patients: rapid and free-of-charge access to new treatments, medicines and laboratory and diagnostic tests, continuous and high-quality medical care.
• Research know-how: Doctors involved in clinical trials significantly improve their skills and knowledge about disease, thereby also significantly improving the quality of services they offer to all patients.
• Enhancing entrepreneurship and employment, with highly qualified scientific human resources.
• Attracting foreign direct investment (FDI), saving resources for the National Health System. For every investment in clinical trials in our country, 20% accrues, mandatorily under the law, to the host hospital and the supervising Healthcare Region, strengthening the budgets of public hospitals in the country.
On the occasion of the International Day for Clinical Trials (20 May), the Hellenic Association of Pharmaceutical Companies (SFEE) has implemented the following actions emphasizing in this way the important role of Clinical Research in defending Public Health.
